Terumo Of Japan To Cease Marketing Two Heart Devices In U.S.
This article was originally published in PharmAsia News
Executive Summary
Japan device-maker Terumo agreed to withdraw two cardiopulmonary-bypass products from the U.S. market after being challenged by the FDA